Stock Taper
Latest 13F filing data - Q2 2026
| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
Ascendis Pharma A/S | ASND | 50K | $13.34M |
Arrowhead Pharmaceuticals, Inc. | ARWR | 50K | $4.08M |
Vaxcyte, Inc. | PCVX | 50K | $2.91M |
Insmed Incorporated | INSM | 75K | $8M |
Cogent Biosciences, Inc. | COGT | 100K | $3.87M |
Tarsus Pharmaceuticals, Inc. | TARS | 100K | $6.29M |
Crinetics Pharmaceuticals, Inc. | CRNX | 125K | $4.68M |
Enliven Therapeutics, Inc. | ELVN | 150K | $7.61M |
Arcutis Biotherapeutics, Inc. | ARQT | 175K | $4.59M |
Odyssey Therapeutics, Inc. | ODTX | 175K | $3.27M |
Amylyx Pharmaceuticals, Inc. | AMLX | 200K | $3.59M |
Spyre Therapeutics, Inc. | SYRE | 225K | $19.98M |
Definium Therapeutics, Inc. | DFTX | 400K | $18.82M |
Roivant Sciences Ltd. | ROIV | 475K | $16.81M |
NewAmsterdam Pharma Company N.V. | NAMS | 500K | $16.95M |
Oruka Therapeutics, Inc. | ORKA | 533.34K | $50.76M |
Kailera Therapeutics, Inc. | KLRA | 550K | $12.12M |
BridgeBio Pharma, Inc. | BBIO | 550K | $40.96M |
Praxis Precision Medicines, Inc. | PRAX | 640K | $214.27M |
Abivax S.A. | ABVX | 675K | $89.95M |